Retrieval-augmented generation breaks at scale because organizations treat it like an LLM feature rather than a platform ...

Rocket Pharmaceuticals is a Buy, with strong catalysts, undervalued programs, and significant upside. Click here to read my ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Minaris will move its center for viral vector innovation to occupy space within CGT Catapult's collaborator laboratories in London and will work with CGT Catapult on the further development of ...

A research team affiliated with UNIST has made a advancement in controlling spin-based signals within a new magnetic material ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

IONQ looks best positioned for 2026, backed by record gate fidelity, a $3.5B cash boost and accelerating commercial momentum ...

The company’s AI-builder approach with in-house AI innovation and bolt-on acquisitions will be key for its growth in the ...

Recently, micro/nanosatellites have become a significant trend in space with the rapid development of space technology, ...

The security company Synthient currently sees more than 2 million infected Kimwolf devices distributed globally but with ...

Data collected under the Death in Custody Reporting Act has some serious problems. Here’s how we fixed some of them.

In 2026, banks face converging pressure from AI, fraud, and data demands. Why hesitation is a competitive risk—and what ...